COVAXIN shows high safety, immunogenicity during phase 1 clinical trial: Lancet journal
Jan 22, 2021
New Delhi [India], January 22 : In a remarkable finding, India's indigenous Covid-19 vaccine--COVAXIN developed by the Bharat Biotech and Indian Council of Medical...